Módszerek összehasonlítása

	Craig Handicap Assessment and Reporting Technique	Impact on Participation and Autonomy
Tudományterület	Rehabilitációtudomány	Rehabilitációtudomány
Módszercsalád	Process / pipeline	Process / pipeline
Keletkezés éve	1992	2001
Megalkotó	Whiteneck, Charlifue, Gerhart, Overholser, Richardson	Cardol, de Haan, de Groot, de Jong
Típus	Interview or Self-report	Self-report or Proxy
Alapmű	Whiteneck, G. G., Charlifue, S. W., Gerhart, K. A., Overholser, J. D., & Richardson, G. N. (1992). Quantifying handicap: a new measure of long-term rehabilitation outcomes. Archives of Physical Medicine and Rehabilitation, 73(6), 519–526.	Cardol, M., de Haan, R. J., de Jong, B. A., van den Bos, G. A., & de Groot, I. J. (2001). Psychometric properties of the Impact on Participation and Autonomy questionnaire. Archives of Physical Medicine and Rehabilitation, 82(2), 210–216.
Alternatív nevek	CHART, CHART-SF	IPA, IPA-Scale
Kapcsolódó	5	5
Összefoglaló	The Craig Handicap Assessment and Reporting Technique (CHART) is a comprehensive interview-based measure designed to quantify how much a disabling condition restricts participation in six key social roles: physical independence, mobility, occupation, social integration, economic self-sufficiency, and cognitive independence. Developed by Whiteneck and colleagues at the Craig Hospital (now national leader in spinal cord injury care), CHART has become the gold-standard outcome measure for long-term spinal cord injury and traumatic brain injury follow-up, extensively used in international outcomes research.	The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherlands by Cardol and colleagues, it operationalizes the WHO handicap concept (now called 'participation restriction') and is widely used in rehabilitation, chronic disease management, and policy evaluation across Europe.